| #100 |
Michael Atlas |
Lightlab Imaging |
2 |
| #100 |
Mark J. Tebbe |
Forma Therapeutics |
2 |
| #100 |
Anders M. Naar |
The General Hospital |
2 |
| #100 |
William Winchin Yen |
Duracell |
2 |
| #100 |
Matthew Dunn |
Liveperson |
2 |
| #100 |
Benjamin J. Vakoc |
The General Hospital |
2 |
| #100 |
Huijun Dong |
Vertex Pharmaceuticals Incorporated |
2 |
| #100 |
Amy D. Travis |
IBM |
2 |
| #100 |
Jane Rempel |
Camx Power |
2 |
| #100 |
Evgeniy Leyvi |
Koniniklijke Philips N.V. |
2 |
| #100 |
Caleb Kennedy |
Good Start Genetics |
2 |
| #100 |
Philip C. Taber |
Silverside Detectors |
2 |
| #100 |
Andrew M. Siegel |
MIT |
2 |
| #100 |
Adam Rodriguez |
Google |
2 |
| #100 |
Jennifer Vandiver |
Alkermes Pharma Ireland Limited |
2 |
| #100 |
Hardeep Singh |
IBM |
2 |
| #100 |
Fabrizio Santini |
Irobot |
2 |
| #100 |
Kevin L. Ward |
Alkermes Controlled Therapeutics |
2 |
| #100 |
Nikita Chugunov |
Schlumberger Technology |
2 |
| #100 |
Nazila Salamat-Miller |
Shire Human Genetic Therapies |
2 |
| #100 |
Howard Sard |
Extend Biosciences |
2 |
| #100 |
William Bradley |
Cambridge Mobile Telematics |
2 |
| #100 |
Brig Barnum Elliott |
Bbn Technologies |
2 |
| #100 |
Brian Steinberg |
Alkermes Pharma Ireland Limited |
2 |
| #100 |
Alfram V. Bright |
Tufts University |
2 |
| #100 |
Peter Boonstra |
Rovi Guides |
2 |
| #100 |
Daniel J. Brooks |
Toyota |
2 |
| #100 |
Katherine Taylor |
Shire Human Genetic Therapies |
2 |
| #100 |
Thomas A. Ohki |
RTX (Raytheon) |
2 |
| #100 |
Lewis D. Girod |
Cambridge Mobile Telematics |
2 |
| #100 |
Peter Smith |
Eisai R&D Management Co. |
2 |
| #100 |
Andrew J. Kerman |
MIT |
2 |
| #100 |
David A. Kirkwood |
Axcelis Technologies |
2 |
| #100 |
David C. Duffy |
Quanterix |
2 |
| #100 |
Richard Garner |
Osram Sylvania |
2 |
| #100 |
Karen Hao |
Unknown |
2 |
| #100 |
Michael Finney |
Bio-Rad Laboratories |
2 |
| #100 |
Deborah Mendez |
Glance Networks |
2 |
| #100 |
Daniel Klebanov |
Boston Scientific Scimed |
2 |
| #100 |
Julia Harper |
Oracle |
2 |
| #100 |
Liwei LI |
Manus Bio |
2 |
| #100 |
Iain McFadyen |
Modernatx |
2 |
| #100 |
Douglas A. Treco |
Transkaryotic Therapies |
2 |
| #100 |
Ronald L. Rivest |
Emc |
2 |
| #100 |
Sunita R. Hett |
Pfizer |
2 |
| #100 |
Brian Cali |
Ironwood Pharmaceuticals |
2 |
| #100 |
Richard Shapiro |
Ab Initio Technology |
2 |
| #100 |
Trevor Percival Castor |
Aphios |
2 |
| #100 |
I. Robert Silverman |
Concert Pharmaceuticals |
2 |
| #100 |
Karen E. Thomas-Alyea |
A123 Systems |
2 |